PrEP is coming to Aotearoa – a logical step to further reduce HIV transmission

+Print Archive
PRACTICE

PrEP is coming to Aotearoa – a logical step to further reduce HIV transmission

Massimo Giola
Aids/HIV
In the absence of a vaccine or a cure, the traditional, condom-based prevention strategies seem unable to stem the HIV tide

Antiretroviral therapy use by an HIV-negative person is not new; post-exposure prophylaxis is common. Now, there is funding for pre-exposure prophylaxis in high-risk individuals. This article is a review of PrEP, as it applies locally, and of the role GPs can play

Key points, From 1 March, PrEP with tenofovir disoproxil fumarate/ emtricitabine has been approved by Pharmac for patients at high-risk of HIV transmission.